Drug Development, Pharmaceutical Manufacturing and White Paper

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Pharmaceutical Manufacturing

White Paper

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Defossilization of pharmaceutical manufacturing. 199‒208.

Compounding

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Drug Development

Drug Development Dosage Pharmaceutical Manufacturing Communication

Pharmacist Digest

Building CO2-neutral, defossilised supply chains for chemicals

The rising importance of containment in small molecule drug development

Stay Connected